CD307b (FcRL2) Antibody, anti-human, Biotin, REAfinity™ 130-107-491 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD307b (FcRL2) Antibody, anti-human, Biotin, REAfinity™

Miltenyi Biotec's CD307b (FcRL2) Antibody, anti-human, Biotin, REAfinity™ is a Human monoclonal antibody. The CD307b (FcRL2) Antibody, anti-human, Biotin, REAfinity™ was generated using Fc receptor like 2, and FCRL2 as the antigen. It reacts with Human. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD307b (FcRL2) Antibody, anti-human, Biotin, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-107-491
Quantity30 tests in 300 µL
ApplicationsFlow cytometry
Conjugate/TagBiotin
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
IsotypeIgG1
CloneREA474
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
Regulatory StatusFor research use only
NCBI Full Gene NameFc receptor like 2
NCBI Gene AliasesCD307b, FCRH2, IFGP4, IRTA4, SPAP1, SPAP1A, SPAP1B, SPAP1C
Clonalitymonoclonal
Concentration1:11
ModificationsRecombinantly engineered
TargetCD307b (FcRL2)
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signallingImmunologyNovember 1, 2014Shabani M, Bayat AA, Jeddi-Tehrani M, Rabbani H, Hojjat-Farsangi M, Ulivieri C, Amirghofran Z, Baldari CT, Shokri F.

(2) FcR-like 2 Inhibition of B cell receptor-mediated activation of B cellsJournal of immunology (Baltimore, Md. : 1950)December 15, 2010Jackson TA, Haga CL, Ehrhardt GR, Davis RS, Cooper MD.

(3) Identification of a family of Fc receptor homologs with preferential B cell expressionProceedings of the National Academy of Sciences of the United States of AmericaAugust 14, 2001Davis RS, Wang YH, Kubagawa H, Cooper MD.

Be the First to Write a Review!